BioHealth News Archive
Boehringer Ingelheim expands Venture Funds to €250m – European Biotechnology
Originally, the BIVF was designed to put investments of up to €10-15m into early stage companies focused on immunomodulation, tissue regeneration, small and large molecule…
Read More
Bluefield Innovations thinks this JHU cancer research could become a new Baltimore company – Technical.ly Baltimore
Cancer research helmed by a Johns Hopkins radiation oncology professor is the first to receive backing from a fund backing work that might create…
Read More
Personal Genome Diagnostics closes $75M Series B, plans second Baltimore office – Technical.ly Baltimore
Canton-based Personal Genome Diagnostics closed on $75 million in Series B funding and plans to triple its square footage with a new office. {iframe}https://technical.ly/baltimore/2018/01/04/personal-genome-diagnostics-closes-75m-series-b-plans-second-baltimore-office/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=59788772&_hsenc=p2ANqtz-8lK_TzsmR3HEtnsa-fx7CpDfP887B5H_xhsLgNCyFZDQ-V2wvMkAMBgTHcijmaTeEr8lf65IgLdjDFo5H65jyuR4l0og&_hsmi=59788772{/iframe}
Read More
WellDoc Validates Potential of Its Digital Therapeutic, BlueStar®, to Significantly Reduce Healthcare Costs
WellDoc®, a leading digital health company, announced today that its clinically proven hemoglobin A1C reductions for users of its BlueStar® digital therapeutic with type…
Read More
‘Hey, Dude, Where’s My Exclusivity?’: United Therapeutics, FDA Tussle – Bloomberg BNA
Silver Spring, Md.-based United Therapeutics Corp. and the FDA are duking it out in court over whether the agency improperly denied the biotechnology company…
Read More
Emergent BioSolutions Initiates Phase 2 Clinical Study to Evaluate FLU-IGIV to Treat Serious Influenza A Infection
Emergent BioSolutions Inc. (NYSE:EBS) today announced the initiation of a Phase 2 dose ranging study to evaluate the safety, pharmacokinetics, and clinical benefit of…
Read More
Xconomy: San Diego Life Sciences 2022: Photos and Takeaways
Making predictions can be a tricky business. Nevertheless, Xconomy recently brought together some of San Diego’s most prominent life sciences leaders to offer their…
Read More
Trump FDA Chief Scott Gottlieb Isn’t Pharma’s BFF After All – Bloomberg Gadfly
Scott Gottlieb seems like the pharmaceutical industry's idea of a dream FDA Commissioner, with pharma ties and an ideological bent toward deregulation. {iframe}https://www.bloomberg.com/gadfly/articles/2018-01-02/trump-fda-chief-scott-gottlieb-isn-t-pharma-s-bff-after-all{/iframe}
Read More
Ex-Pfizer CEO’s startup Centrexion gets $67M for PhIII painkiller – Endpoints News
Centrexion Therapeutics, a Boston-based startup led by ex-Pfizer CEO Jeff Kindler, just raised $67 million to bring its painkiller drug into Phase III trials.…
Read More
Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018
Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-steroidal therapeutics for the treatment of chronic pain, today announced the successful completion of a…
Read More
NexImmune Raises $23 Million to Advance Endogenous Cellular ImmunoTherapy into Clinical Development | Markets Insider
NexImmune, an emerging leader in the field of antigen-directed immunotherapy, announced the closing of a Series A financing co-led by new investor ArrowMark Partners…
Read More
7 Key Cancer Trends For 2018
I expect progress. Here’s my list of major trends and issues that will affect the lives of cancer patients in 2018: {iframe}https://www.forbes.com/sites/elaineschattner/2017/12/31/7-key-cancer-trends-for-2018/#a6fde1a2d0e7{/iframe}
Read More
Hopkins-born startup PathoVax wins $2.5 million, nears clinical trial readiness – Baltimore Business Journal
The grants came through the National Institute of Allergy and Infectious Diseases and the National Science Foundation. {iframe}https://www.bizjournals.com/baltimore/news/2017/12/29/hopkins-born-biotech-startup-wins-2-5-million.html{/iframe}
Read More
Graduate School Open House Spring 2018 – FAES
Join us on Thursday, January 11 for the 2017-18 Spring Term FAES Graduate School Open House to meet and mingle with FAES faculty. Bring…
Read More
J.P. Morgan’s head of life sciences for commercial banking shares biopharma industry insights for 2018 (Q&A) – MedCity News
The biopharma sector has had quite a year. Under FDA Commissioner Scott Gottlieb, the regulator approved a record number of drugs and helped usher…
Read More